STOCK TITAN

Quest Diagnostics to Speak at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 10:30 a.m. Eastern Time. CEO Jim Davis and CFO Sam Samad will discuss the company's performance, strategy, and market trends. The live presentation will be webcast and available on their investor relations page. An archived version will be accessible within 24 hours and remain available until February 10, 2023.

Quest Diagnostics aims to empower individuals to enhance health outcomes through diagnostic insights.

Positive
  • None.
Negative
  • None.

SECAUCUS, N.J., Jan. 4, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 41st Annual J.P. Morgan Healthcare Conference. Jim Davis, CEO and President, and Sam Samad, Executive Vice President and CFO, will discuss the company's performance, and strategy, and the latest market developments and trends. The presentation is scheduled for Wednesday, January 11, 2023, at 10:30 a.m. Eastern Time.  

The presentation and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com.  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 10, 2023.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-41st-annual-jp-morgan-healthcare-conference-301713756.html

SOURCE Quest Diagnostics

FAQ

When is Quest Diagnostics scheduled to speak at the J.P. Morgan Healthcare Conference?

Quest Diagnostics will speak at the J.P. Morgan Healthcare Conference on January 11, 2023.

Who will represent Quest Diagnostics at the J.P. Morgan Healthcare Conference?

Jim Davis, CEO, and Sam Samad, CFO, will represent Quest Diagnostics at the conference.

What time is the Quest Diagnostics presentation at the conference?

The Quest Diagnostics presentation is scheduled for 10:30 a.m. Eastern Time.

Where can I watch the Quest Diagnostics conference presentation?

The presentation can be watched live on Quest Diagnostics' investor relations page.

Will there be a recording of the Quest Diagnostics presentation available?

Yes, an archived version will be available within 24 hours after the live event until February 10, 2023.

What topics will be discussed during the Quest Diagnostics presentation?

The presentation will cover the company's performance, strategy, and latest market developments.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

17.08B
111.10M
0.43%
91.58%
1.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SECAUCUS